Skip to main content

Grants

Grants

Asaf Keller

  • Among the recipients of a $200,000/year UMCP & UMB - Artificial Intelligence + Medicine for High Impact (AIM-HI) Challenge Award for “Precision Therapy for Neonatal Opioid Withdrawal Syndrome,” effective February 15, 2020.
  • Five-year, $2.4 million grant from the National Institute of Neurological Disorders and Stroke (NIH NINDS), titled "Serotonin and Pain Modulation," effective June 1, 2019.

Sam Bacharach, Graduate Student, Program in Neuroscience in the laboratory of Donna Calu

  • Three-year, $38,376 Predoctoral National Research Service Award from the National Institute of Drug Abuse (NIH/NIDA) for "The Role of Cannabinoid Receptor-1 in Modulating Addiction Vulnerability." Joseph Cheer Professor, Department of Anatomy and Neurobiology was co-sponsor.

Donna Calu

  • Five-year $1,931,250 (total costs) R01 from the National Institute on Drug Abuse to examine the “Role of basolateral amygdala projections in mediating individual differences in motivation and flexibility.” 
  • Three-year, $300,000 McKnight Memory and Cognitive Disorders Award for her investigation of “Individual Differences in Attention Signaling in Amygdala Circuits.”
  • Two-year $70,000 2016 Young Investigator Grant from The Brain and Behavior Research Fund, for her investigation of the “Role of amygdala projections in the incubation of fear and drug craving.”

Ramesh Chandra

  • Two-year, $70,000 2015 NARSAD Young Investigator Grant titled "Cell Subtype Molecular Mechanisms of Mitochondria Dynamics in Depression."

Mary Kay Lobo 

  • U01 grant from NIDA. This large Cooperative Agreement is titled "Heroin-Induced genomic regulation of Ventral Pallidum neuron subtypes".

Joseph Cheer

  • Five-year, $1,738,125 grant from the National Institute on Drug Abuse (NIDA/NIH) for “Cannabinoid Receptor Control of a DRN to VTA Pathway and its Role in the Affective States,” effective March 1, 2019.  Also within Dr. Cheer's lab, Dan Covey, Assistant Professor, was awarded a $1,051,544 K99/R00 award from the NIDA/NIH for “Neural Circuit Control of Mesolimbic Dopamine and Reward,” effective February 2019.
  • Five-year $2,200,000 R01 from the National Institute on Drug Abuse to examine the long-term consequences of Ritalin and marijuana exposure in adolescence.

Reha S. Erzurumlu

  • Five-year, $2,500,000 renewal of his existing R01 grant “Consequences of developmental defects in somatosensory map formation” from the National Institute of Neurological Disorders and Stroke (NINDS/NIH).
  • One-year $381,304 supplement to his existing R01 grant, from the National Institute of Neurological Disorders and Stroke (NINDS) for “Thalamocortical circuit defects in developmental brain disorders,” effective September 1, 2019.
  • Five-year $2,475,313 R01 grant, along with Dr. Elizabeth Powell, from the National Institutes of Neurological Disorders and Stroke (NINDS) for “Thalamocortical circuit defects in developmental brain disorders.”  The goal of the project is to define sensory thalamocortical synaptic defects in mouse models of Autism Spectrum Disorders.

Megan E. FoxPostdoctoral Fellow in the laboratory of Mary Kay Lobo

  • Two-year K99 $351,584 award from the National Institute on Drug Abuse (NIDA) for "Circuit-Specific Molecular Mechanisms in Fentanyl Use and Relapse," effective April 1, 2020.

Iris Lindberg

  • Supplement for NIH grant from the Alzheimer’s Disease Initiative funds  The parent grant is titled: Cyto-ProSAAS Chaperone Action in Alzheimer's Disease and Frontotemporal Dementia.
  • Five-year $2.6 million (direct costs) grant, along with Dr. Nigel Maidment, Co-PI, (UCLA), effective February 1, 2019, from the National Institute on Aging (NIA) for “ProSAAS-mediated neuroprotective mechanisms in Alzheimer’s and Parkinson’s diseases: The role of secretory chaperones in neurodegeneration.”
  • Five-year R01 grant from the National Institute on Drug Abuse (NIDA) entitled “Opioid Peptide Synthesizing Enzymes” for 2.1 million dollars (total costs).
  • Two-year, $456,663 grant from NIH and the National Institute on Aging for "The Secretory Chaperone 7B2 as Endogenous Regulator of Amyloid Pathology.”

Shaolin Liu

  • Five-year $1,304,750 grant from the National Institute on Deafness and other Communication Disorders for “Functional Mechanisms Underlying the Intrabulbar Associational Circuit in the Olfactory System.”

Mary Kay Lobo

  • U01 grant from NIDA. This large Cooperative Agreement is titled "Heroin-Induced genomic regulation of Ventral Pallidum neuron subtypes".
  • Five-year $1,617,772 RO1 award from the National Institute on Mental Health (NIMH) for "Cell Subtype Mechanisms Underlying Stress Susceptibility and Resilience," effective April 1, 2020.
  • Five-year $2,171,420 grant, effective February 1, 2019, from the National Institute of Drug Abuse for “Ventral pallidum molecular mediators in cocaine addiction.”
  • Two-year $60,000 start-up research grant from the US-Israel Binational Science Foundation for “Genetics and physiology of ventral pallidum microcircuits.”  
  • Tree-year $500,000 grant from the National Science Foundation on "Focused electrical stimulator for targeted neuromodulation.”
  • Three-year $250,000IMHRO Janssen Rising Star Translational Research Award for “Stabilizing neuronal architecture for Depression therapeutics.”
  • Five-year, $1,918,750 R01 grant from the National Institute of Mental Health (NIMH) for "The Neurocircuitry of Depression: Molecular and Cell Subtype Mechanisms”.
  • Five-year, $1,918,750 grant from the National Institute on Drug Abuse (NIDA) for "Cell Subtype Transcriptional Mechanisms in Cocaine Addition.”

Dennis Sparta

  • Five-year $1,125,000 (direct costs) grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the project “CRF Neural Circuits of Binge Drinking,” effective, April 12, 2019.
  • Three-year $736,215 continuation award for a K99 grant from the NIH and the National Institute on Alcohol Abuse and Alcoholism for "The Role of the BNST to VTA Neural Circuit in Binge Alcohol Consumption."

Natalie Zlebnik

  • $1,061,248 K99/R00 Pathway to Independence Grant, effective August 1, 2019, from the National Institute on Drug Abuse (NIDA/NIH) for “Effects of exercise on dopaminergic mechanisms of cocaine relapse.”